Literature DB >> 8099942

Accessory cell-derived signals required for T cell activation.

J G Johnson1, M K Jenkins.   

Abstract

Various populations of accessory cells differ in their abilities to function as effective antigen-presenting cells (APC) and stimulate CD4+ T cells to produce interleukin-2. Three important factors directly related to APC potency are the expression of class II major histocompatibility complex molecules and the ability to present peptide antigens to the T cell antigen receptor, the expression of costimulatory ligands which deliver important activation signals independent of T cell receptor occupancy and the expression of adhesion molecules which promote conjugate formation so that these activation signals can be effectively delivered to the T cells. The relative importance of these accessory cell functions in T cell activation will be discussed, with an emphasis on costimulation and the CD28/B7 receptor/ligand pair. The consequence of inadequate costimulation by an otherwise effective APC in inducing T cell anergy will also be discussed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8099942     DOI: 10.1007/bf02918368

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  97 in total

1.  A nondeletional mechanism of thymic self tolerance.

Authors:  F Ramsdell; T Lantz; B J Fowlkes
Journal:  Science       Date:  1989-11-24       Impact factor: 47.728

2.  T helper cell subsets require the expression of distinct costimulatory signals by antigen-presenting cells.

Authors:  C T Weaver; C M Hawrylowicz; E R Unanue
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

3.  Antigen presentation by keratinocytes induces tolerance in human T cells.

Authors:  V Bal; A McIndoe; G Denton; D Hudson; G Lombardi; J Lamb; R Lechler
Journal:  Eur J Immunol       Date:  1990-09       Impact factor: 5.532

4.  Identification of a zinc finger protein that inhibits IL-2 gene expression.

Authors:  T M Williams; D Moolten; J Burlein; J Romano; R Bhaerman; A Godillot; M Mellon; F J Rauscher; J A Kant
Journal:  Science       Date:  1991-12-20       Impact factor: 47.728

5.  Defining protective responses to pathogens: cytokine profiles in leprosy lesions.

Authors:  M Yamamura; K Uyemura; R J Deans; K Weinberg; T H Rea; B R Bloom; R L Modlin
Journal:  Science       Date:  1991-10-11       Impact factor: 47.728

6.  Identification and distribution of the costimulatory receptor CD28 in the mouse.

Authors:  J A Gross; E Callas; J P Allison
Journal:  J Immunol       Date:  1992-07-15       Impact factor: 5.422

7.  Interleukin-1 stimulates diacylglycerol production in T lymphocytes by a novel mechanism.

Authors:  P M Rosoff; N Savage; C A Dinarello
Journal:  Cell       Date:  1988-07-01       Impact factor: 41.582

8.  Heat-stable antigen is a costimulatory molecule for CD4 T cell growth.

Authors:  Y Liu; B Jones; A Aruffo; K M Sullivan; P S Linsley; C A Janeway
Journal:  J Exp Med       Date:  1992-02-01       Impact factor: 14.307

9.  Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression.

Authors:  R de Waal Malefyt; J Haanen; H Spits; M G Roncarolo; A te Velde; C Figdor; K Johnson; R Kastelein; H Yssel; J E de Vries
Journal:  J Exp Med       Date:  1991-10-01       Impact factor: 14.307

10.  Downregulation of Th1 cytokine production accompanies induction of Th2 responses by a parasitic helminth, Schistosoma mansoni.

Authors:  E J Pearce; P Caspar; J M Grzych; F A Lewis; A Sher
Journal:  J Exp Med       Date:  1991-01-01       Impact factor: 14.307

View more
  10 in total

1.  Molecular characterization of U937-dependent T-cell co-stimulation.

Authors:  T J Stonehouse; V E Woodhead; P S Herridge; H Ashrafian; M George; B M Chain; D R Katz
Journal:  Immunology       Date:  1999-01       Impact factor: 7.397

2.  Roles for CD40, B7 and major histocompatibility complex in induction of enhanced immunity by cryptococcal polysaccharide-pulsed antigen-presenting cells.

Authors:  Rebecca Blackstock
Journal:  Immunology       Date:  2003-02       Impact factor: 7.397

3.  Constitutive expression of the HTLV-I pX and env regions in Jurkat T-cells induces differential activation of SRE, CRE and NF kappa B pathways.

Authors:  A C Black; J Luo; S Chun; S Tabibzadeh
Journal:  Virus Genes       Date:  1997       Impact factor: 2.332

4.  Phenothiazine-induced increase in thyroid autoantigens and costimulatory molecules on thyroid cells: a pathophysiological mechanism for drug-induced autoimmunity?

Authors:  L Takorabet; A Ropars; L Stasiuk; C Raby; J Charreire
Journal:  Clin Exp Immunol       Date:  1998-02       Impact factor: 4.330

Review 5.  Induction of transplantation tolerance in non-human primate preclinical models.

Authors:  Douglas A Hale; Kiran Dhanireddy; David Bruno; Allan D Kirk
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2005-09-29       Impact factor: 6.237

Review 6.  Potential targeting of B7-H4 for the treatment of cancer.

Authors:  Joseph R Podojil; Stephen D Miller
Journal:  Immunol Rev       Date:  2017-03       Impact factor: 12.988

Review 7.  Targeting the B7 family of co-stimulatory molecules: successes and challenges.

Authors:  Joseph R Podojil; Stephen D Miller
Journal:  BioDrugs       Date:  2013-02       Impact factor: 5.807

8.  Construction, purification, and functional incorporation on tumor cells of glycolipid-anchored human B7-1 (CD80).

Authors:  R S McHugh; S N Ahmed; Y C Wang; K W Sell; P Selvaraj
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-15       Impact factor: 11.205

Review 9.  Accessory molecule regulation of naive CD4 T cell activation.

Authors:  C Dubey; M Croft
Journal:  Immunol Res       Date:  1996       Impact factor: 2.829

Review 10.  Immunity to Pathogens Taught by Specialized Human Dendritic Cell Subsets.

Authors:  Jens Geginat; Giulia Nizzoli; Moira Paroni; Stefano Maglie; Paola Larghi; Steve Pascolo; Sergio Abrignani
Journal:  Front Immunol       Date:  2015-10-13       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.